Silver nanoparticle risks and benefits: Seven things worth knowing

What are the benefits and risks of using silver nanoparticles in consumer products, including colloidal silver? Risk Bites' Andrew Maynard looks at seven things you should know about this nanomaterial. Silver nano has been hitting the headlines for a few years now, both as a smart new technology for preventing bacterial infection, and as a potential new health and environmental threat. But what's the science behind how it behaves, and how it might be beneficial, or harmful? We take a look at seven things worth knowing about silver nanoparticles -- some of which may surprise you! For more information on silver nanoparticles, check out the links below. The Risk Bites Team: Andrew Maynard David Faulkner Alyssa Berry Backing track: Based on Blue and Green by Rimsky. FURTHER INFORMATION AND READING Nanoparticles and their size may not be big issues. University of Oregon. Colloidal silver: Is it safe or effective? Mayo Clinic. Nanosilver: Weighing the Risks and Benefits. Environmental Health Perspectives. Nanosilver and consumer products. EPA Some antibacterials come with worrisome silver lining. Chicago Tribune, Feb 15 2014.,0,204673.story Project on Emerging Nanotechnologies Consumer Products Inventory: Nano Silver X-static Crypton Fabric Risk Bites is your guide to making sense of risk. We cover everything from understanding and balancing the risks and benefits of everyday products, to health science more broadly, to the potential impacts of emerging technologies, to making sense of risk perception. If you enjoy our videos, please subscribe, and spread the word! Click here to see more videos:

LicenseCreative Commons Attribution-ShareAlike

More videos by this producer

23andMe, FDA and DNA health profiling

Are companies that provide direct-to-consumer information on their personal genome -- including genetic susceptibility to disease -- creating new health risks that need to be regulated? On November 22 2013, the US Food and Drug Administration requested that the personalized DNA analysis company 23a